DEW - Why don't you call Dr. Levitt personally or Investor Relations and talk to them about your concerns below. I see no reason why they/he wouldn't talk to you about this. Also, do you think GENR's top management/investor relations reads this board? Thanks to everyone for all of their posts about the R&R presentation....10nis
>> we are toying around with ruminating (about dosing frequencies) before we indeed know the scientific proof of Squalamine’s probable efficacy. <<
We are discussing the dosing frequency and possible subcutaneous administration because Dr. Levitt mentioned these matters in his talk. Our job is to figure out why he did, and I don’t think we have a convincing answer yet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.